Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| MEDGENICS, INC. | 238,000 | reported | 14 Jun 2018 | tx 6+1,338,000 |
| Sana Biotechnology, Inc. | 200,000 | reported | 17 Feb 2026 | tx 2+1,100,000 |
| Prelude Therapeutics Inc | 2,344 | reported | 25 Aug 2021 | tx 12+132,316−33,332 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Feb 2026 | GRANT_AWARD | Sana Biotechnology, Inc. | 200,000 | 0.00 USD | deriv |
| 17 Feb 2026 | GRANT_AWARD | Sana Biotechnology, Inc. | 900,000 | 0.00 USD | deriv |
| 25 Aug 2021 | SALE | Prelude Therapeutics Inc | 2,344 | 34.33 USD | |
| 25 Aug 2021 | EXERCISE | Prelude Therapeutics Inc | 8,333 | 1.89 USD | |
| 25 Aug 2021 | SALE | Prelude Therapeutics Inc | 2,100 | 32.44 USD | |
| 25 Aug 2021 | SALE | Prelude Therapeutics Inc | 3,889 | 33.23 USD | |
| 25 Aug 2021 | EXERCISE | Prelude Therapeutics Inc | 8,333 | 0.00 USD | deriv |
| 20 Jul 2021 | GRANT_AWARD | Prelude Therapeutics Inc | 115,650 | 0.00 USD | deriv |
| 25 May 2021 | SALE | Prelude Therapeutics Inc | 3,110 | 33.53 USD | |
| 25 May 2021 | SALE | Prelude Therapeutics Inc | 399 | 36.09 USD | |
| 25 May 2021 | SALE | Prelude Therapeutics Inc | 3,088 | 34.11 USD | |
| 25 May 2021 | EXERCISE | Prelude Therapeutics Inc | 8,333 | 1.89 USD | |
| 25 May 2021 | SALE | Prelude Therapeutics Inc | 1,736 | 35.45 USD | |
| 25 May 2021 | EXERCISE | Prelude Therapeutics Inc | 8,333 | 0.00 USD | deriv |
| 14 Jun 2018 | GRANT_AWARD | MEDGENICS, INC. | 238,000 | 0.00 USD | deriv |
| 14 May 2018 | GRANT_AWARD | MEDGENICS, INC. | 270,000 | 0.00 USD | deriv |
| 11 Aug 2017 | GRANT_AWARD | MEDGENICS, INC. | 380,000 | 0.00 USD | deriv |
| 17 Feb 2017 | GRANT_AWARD | MEDGENICS, INC. | 190,000 | 0.00 USD | deriv |
| 15 Apr 2016 | GRANT_AWARD | MEDGENICS, INC. | 150,000 | 0.00 USD | deriv |